Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans.
The treatment of soft tissue tumors needs the coordinated adoption of surgery with radiation therapy and eventually, chemotherapy. The radiation therapy (delivered with a linear accelerator) can be preoperative, intraoperative, or postoperative. In selected patients adjuvant brachytherapy can be adopted. The goal of these associations is to achieve tumor control while maximally preserving the normal tissues from side effects. Unfortunately, the occurrence of local and distant complications is still elevated. Electrochemotherapy is a novel technique that combines the administration of anticancer agents to the application of permeabilizing pulses in order to increase the uptake of antitumor molecules. While its use in humans is still confined to the treatment of cutaneous neoplasms or the palliation of skin tumor metastases, in veterinary oncology this approach is rapidly becoming a primary treatment. This review summarizes the recent progresses in preclinical oncology and their possible transfer to humans.
Spugnini
Enrico P
EP
S.A.F.U. Department, Regina Elena Cancer Institute, Rome, Italy. info@enricospugnini.net
Citro
Gennaro
G
Baldi
Alfonso
A
D000818:Animals; D017024:Chemotherapy, Adjuvant / Q000379:methods; D004195:Disease Models, Animal; D053672:Electrochemotherapy / Q000379:methods / Q000662:veterinary*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000662:veterinary*; D018714:Radiotherapy, Adjuvant / Q000379:methods
Biochem Biophys Res Commun. 1993 Jul 15;194(1):333-7
7687434
Methods Enzymol. 1990;184:641-53
2167431
J Exp Clin Cancer Res. 2007 Dec;26(4):483-7
18365542
Anticancer Res. 2001 Jul-Aug;21(4A):2483-8
11724311
In Vivo. 2008 Jan-Feb;22(1):47-9
18396781
Vet Rec. 2006 Oct 28;159(18):598-600
17071674
J Exp Clin Cancer Res. 2008 Nov 12;27:67
19014470
Technol Cancer Res Treat. 2002 Oct;1(5):393-9
12625765
Surg Gynecol Obstet. 1993 Feb;176(2):124-34
8421799
Lancet. 2002 Jun 29;359(9325):2235-41
12103287
J Surg Oncol. 1993 Apr;52(4):223-30
8468983
Planta. 1981 Jan;151(1):26-32
24301666
IEEE Eng Med Biol Mag. 1999 Jan-Feb;18(1):62-6
9934602
Cancer Res. 1993 Nov 15;53(22):5462-9
7693342
In Vivo. 2007 Sep-Oct;21(5):819-22
18019417
J Exp Clin Cancer Res. 2005 Jun;24(2):245-54
16110758
Biophys Chem. 1984 May;19(3):211-25
6722274
Expert Rev Anticancer Ther. 2009 Feb;9(2):199-210
19192958
Br J Cancer. 1997;76(12):1617-22
9413951
In Vivo. 2008 Jan-Feb;22(1):51-3
18396782
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1476-80
19231097
Cancer Chemother Pharmacol. 2007 Feb;59(3):375-81
16807731
Gene Ther. 2002 Oct;9(19):1286-90
12224011
Methods Mol Biol. 2008;433:115-25
18679620
Melanoma Res. 2006 Feb;16(1):23-7
16432452
J Exp Clin Cancer Res. 2007 Sep;26(3):343-6
17987793
Eur J Surg Oncol. 2009 Jun;35(6):568-72
19013049
J Transl Med. 2007 Oct 02;5:48
17910745
Breast Cancer Res Treat. 2009 Sep;117(2):333-8
19152026
Br J Cancer. 2008 Jan 29;98(2):388-98
18182988
Microsc Res Tech. 2007 Dec;70(12):1041-50
17722056
Cancer. 2002 Feb 1;94(3):786-92
11857314
Anticancer Res. 2006 Nov-Dec;26(6B):4585-9
17201181
Ther Clin Risk Manag. 2008 Apr;4(2):541-8
18728828
Cancer Treat Rev. 2005 Nov;31(7):555-70
16168567
J Exp Clin Cancer Res. 2003 Dec;22(4):571-80
15053299
Int J Hyperthermia. 1994 May-Jun;10(3):429-32
7930810
Vet J. 2009 Jan;179(1):117-20
17904882
Vet J. 2008 Nov;178(2):291-3
17910926
In Vivo. 2008 Nov-Dec;22(6):751-3
19181001
In Vivo. 2007 Sep-Oct;21(5):897-9
18019432
BMC Cancer. 2005 Sep 16;5:115
16168056